Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Neoplasms 3Prostatic Neoplasms 2Fatigue 2Breast Neoplasms 2Xerostomia 1Vomiting 1Uterine Cervical Neoplasms 1Psychological Well-Being 1Parasomnias 1Pancreatic Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Obesity 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nausea 1Multiple Myeloma 1Mucositis 1Motor Activity 1Mesothelioma 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Lung Diseases 1Liver Neoplasms 1Hyperinsulinism 1Head and Neck Neoplasms 1Esophagitis 1Digestive System Diseases 1Colon or Upper Rectum Adenocarcinoma 1Brain Neoplasms 1

Interventions

Carboplatin 6Pemetrexed 4pembrolizumab 3Cisplatin 3Paclitaxel 2Gemcitabine 2Docetaxel 2zipalertinib 1zimberelimab 1sacituzumab govitecan 1pralsetinib 1patritumab 1camrelizumab 1alectinib 1Vinorelbine 1Thrombin 1Talc 1TachoSil 1TNFSF10 protein, human 1Surveys and Questionnaires 1Nivolumab 1Injections 1Fibrinogen 1Erlotinib Hydrochloride 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lung Diseases × Surveys and Questionnaires × Clear all
NCT02511600 2015-12-15

Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication

M.D. Anderson Cancer Center

Phase 3 Withdrawn
Other solid neoplasmThoracic

Lung Diseases, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡